More Company News

MaxCyte

CARMA Phase I trial progresses
08 May 2019Read More

MaxCyte

FY18 results
24 Apr 2019Read More

MaxCyte

Launch of ExPERT instrument family
08 Apr 2019Read More

MaxCyte

Clinical and commercial agreement with Kite
01 Mar 2019Read More

MaxCyte

Results of placing
05 Feb 2019Read More

MaxCyte

Proposed placing to raise a minimum of £10m
05 Feb 2019Read More

MaxCyte

Trading update
15 Jan 2019Read More

MaxCyte

Consolidation of trading lines
21 Nov 2018Read More

MaxCyte

Clinical and commercial license agreement
14 Nov 2018Read More

MaxCyte

Research agreement with Kite
12 Nov 2018Read More

1 2 3 4
Return to MaxCyte
© 2019 Trinity Delta. All rights reserved. Trinity Delta is regulated by the Financial Conduct Authority (Reference number: 725161).